儿童鼓膜置管临床实践指南(更新版)执行摘要
本执行摘要基于美国耳鼻咽喉头颈外科学会基金会更新的《儿童鼓膜置管临床实践指南》,为6个月至12岁儿童中耳炎鼓膜置管的患者选择与手术指征提供循证推荐。指南对14条关键行动声明给出推荐强度:2条强推荐、11条推荐、3条可选。
要点
- 无并发症的急性鼓膜置管后耳漏,仅推荐局部抗生素滴耳液,不口服抗生素(强推荐)。
- 置管后3个月内应检查鼓膜并教育家庭定期随访直至通气管脱出(强推荐)。
- 单纯OME不足3个月、或复发AOM评估时无中耳积液者,不推荐置管。
核心结论
- 指南更新为儿童鼓膜置管的患者选择与手术指征提供循证推荐,取代2013年版指南。
- 执行摘要不能替代完整指南,临床医生在实施推荐措施前应阅读完整指南。
研究设计与样本
- 指南更新采用美国耳鼻咽喉头颈外科学会基金会《临床实践指南制定手册(第三版):以质量为导向将证据转化为行动》所述方法制定。
- 指南更新小组代表耳鼻咽喉头颈外科、耳科、儿科、听力学、麻醉学、家庭医学、高级实践护理、言语语言病理学和消费者权益倡导等学科。
- 目标人群为6个月至12岁患有任何类型中耳炎、正在接受或考虑接受鼓膜置管的儿童。
主要发现
- 强推荐:无并发症急性鼓膜置管后耳漏仅处方局部抗生素滴耳液,不用口服抗生素(声明14)。
- 强推荐:置管后3个月内检查耳部并教育家庭定期随访直至通气管脱出(声明16)。
- 推荐:自起病日(已知)或诊断日(起病未知)起OME不足3个月的单次发作不应置管(声明1)。
- 推荐:OME持续3个月或以上应行听力评估,或在儿童成为置管候选者时术前评估(声明2)。
- 推荐:双侧OME持续3个月或以上且有听力困难证据的儿童,应提供双侧置管(声明3)。
关键数值与推荐
- 强推荐(声明14):无并发症急性鼓膜置管后耳漏仅用局部抗生素滴耳液,不用口服抗生素。
- 强推荐(声明16):置管后3个月内检查耳部并教育家庭定期随访直至通气管脱出。
- 推荐(声明1):OME不足3个月(自起病日或诊断日起)不行置管。
- 推荐(声明3):双侧OME持续3个月或以上且记录到听力困难,提供双侧置管。
- 推荐(声明15):不鼓励常规预防性防水措施(耳塞、头带、避免游泳或水上运动)。
临床怎么用
- 临床医生应依据指南关键行动声明选择鼓膜置管患者并确定手术指征。
- 执行摘要供参与管理6个月至12岁鼓膜置管或考虑置管儿童的各类临床医生使用,包括专科医生、基层医生和 allied health professionals。
- 临床医生在实施推荐措施前应阅读完整指南,执行摘要不能替代完整指南。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This executive summary of the guideline update provides evidence-based recommendations for patient selection and surgical indications for managing tympanostomy tubes in children. The summary and guideline are intended for any clinician involved in managing children aged 6 months to 12 years with tympanostomy tubes or children being considered for tympanostomy tubes in any care setting as an intervention for otitis media of any type. The target audience includes specialists, primary care clinicians, and allied health professionals. PURPOSE: The purpose of this executive summary is to provide a succinct overview for clinicians of the key action statements (recommendations), summary tables, and patient decision aids from the update of the American Academy of Otolaryngology-Head and Neck Surgery Foundation's "Clinical Practice Guideline: Tympanostomy Tubes in Children (Update)." The new guideline updates recommendations in the prior guideline from 2013 and provides clinicians with trustworthy, evidence-based recommendations on patient selection and surgical indications for managing tympanostomy tubes in children. This summary is not intended to substitute for the full guideline, and clinicians are encouraged to read the full guideline before implementing the recommended actions. METHODS: The guideline on which this summary is based was developed using methods outlined in the American Academy of Otolaryngology-Head and Neck Surgery Foundation's "Clinical Practice Guideline Development Manual, Third Edition: A Quality-Driven Approach for Translating Evidence Into Action," which were followed explicitly. The guideline update group represented the disciplines of otolaryngology-head and neck surgery, otology, pediatrics, audiology, anesthesiology, family medicine, advanced practice nursing, speech-language pathology, and consumer advocacy. ACTION STATEMENTS: Strong recommendations were made for the following key action statements: (14) Clinicians should prescribe topical antibiotic ear drops only, without oral antibiotics, for children with uncomplicated acute tympanostomy tube otorrhea. (16) The surgeon or designee should examine the ears of a child within 3 months of tympanostomy tube insertion AND should educate families regarding the need for routine, periodic follow-up to examine the ears until the tubes extrude.Recommendations were made for the following key action statements: (1) Clinicians should not perform tympanostomy tube insertion in children with a single episode of otitis media with effusion (OME) of less than 3 months' duration, from the date of onset (if known) or from the date of diagnosis (if onset is unknown). (2) Clinicians should obtain a hearing evaluation if OME persists for 3 months or longer OR prior to surgery when a child becomes a candidate for tympanostomy tube insertion. (3) Clinicians should offer bilateral tympanostomy tube insertion to children with bilateral OME for 3 months or longer AND documented hearing difficulties. (5) Clinicians should reevaluate, at 3- to 6-month intervals, children with chronic OME who do not receive tympanostomy tubes, until the effusion is no longer present, significant hearing loss is detected, or structural abnormalities of the tympanic membrane or middle ear are suspected. (6) Clinicians should not perform tympanostomy tube insertion in children with recurrent acute otitis media (AOM) who do not have middle ear effusion (MEE) in either ear at the time of assessment for tube candidacy. (7) Clinicians should offer bilateral tympanostomy tube insertion in children with recurrent AOM who have unilateral or bilateral MEE at the time of assessment for tube candidacy. (8) Clinicians should determine if a child with recurrent AOM or with OME of any duration is at increased risk for speech, language, or learning problems from otitis media because of baseline sensory, physical, cognitive, or behavioral factors. (10) The clinician should not place long-term tubes as initial surgery for children who meet criteria for tube insertion unless there is a specific reason based on an anticipated need for prolonged middle ear ventilation beyond that of a short-term tube. (12) In the perioperative period, clinicians should educate caregivers of children with tympanostomy tubes regarding the expected duration of tube function, recommended follow-up schedule, and detection of complications. (13) Clinicians should not routinely prescribe postoperative antibiotic ear drops after tympanostomy tube placement. (15) Clinicians should not encourage routine, prophylactic water precautions (use of earplugs or headbands, avoidance of swimming or water sports) for children with tympanostomy tubes.Options were offered from the following key action statements: (4) Clinicians may perform tympanostomy tube insertion in children with unilateral or bilateral OME for 3 months or longer (chronic OME) AND symptoms that are likely attributable, all or in part, to OME that include, but are not limited to, balance (vestibular) problems, poor school performance, behavioral problems, ear discomfort, or reduced quality of life. (9) Clinicians may perform tympanostomy tube insertion in at-risk children with unilateral or bilateral OME that is likely to persist as reflected by a type B (flat) tympanogram or a documented effusion for 3 months or longer. (11) Clinicians may perform adenoidectomy as an adjunct to tympanostomy tube insertion for children with symptoms directly related to the adenoids (adenoid infection or nasal obstruction) OR in children aged 4 years or older to potentially reduce future incidence of recurrent otitis media or the need for repeat tube insertion.
引用
- Rosenfeld RM, Tunkel DE, Schwartz SR, et al. Executive Summary of Clinical Practice Guideline on Tympanostomy Tubes in Children (Update). Otolaryngol Head Neck Surg. 2022. PMID: 35138976. doi:10.1177/01945998211065661
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。